Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Transgenic ATIII proven safe in healthy volunteers

Oct. 25, 1996

Promising preliminary phase II results for argatroban in acute MI

Oct. 25, 1996

Servier selects TxA2 antagonist for further study

Oct. 18, 1996

Antiplatelet agents from Taisho

Oct. 18, 1996

Antithrombotic prostaglandin analogue revealed by Asahi Glass

Oct. 18, 1996

BASF reports on novel thrombin inhibitors

Oct. 18, 1996

Bristol-Myers Squibb to develop Toray antiplatelet agent in the U.S. and Canada

Oct. 11, 1996

Fujisawa's antiplatelet agent in clinical trials

Oct. 11, 1996

Integrin receptor antagonists described by SKB

Oct. 11, 1996

Antiplatelet fibrinogen antagonists from Yamanouchi

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...